Skip to main content
Erschienen in: Endocrine 1/2010

01.02.2010 | Original Article

Interleukin 1 beta (IL-1β) promoter C [−511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome

verfasst von: Yuan Mu, Jingjing Liu, Binbin Wang, Qiaolian Wen, Jing Wang, Jinting Yan, Sirui Zhou, Xu Ma, Yunxia Cao

Erschienen in: Endocrine | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

PCOS is a complex multifactorial disorder involving a number of genetic and environmental factors. One of the genetic factors that has been associated with PCOS is Interleukin 1 beta (IL-1β), is an important inflammatory cytokine that plays a regulatory role in both the body’s immune and the inflammatory responses. All these responses appear to be are also affected in at least some women with PCOS. To investigate the possible association of polymorphisms of the IL-1β gene with the occurrence and clinical characteristics of PCOS, we evaluated two common polymorphisms of the IL-1β gene (promoter C [−511] T and exon 5 position [+3953]) in 200 Chinese women with PCOS and 177 healthy Chinese controls. We found the frequency of IL-1β C/C [−511] genotype in PCOS was significantly higher than that in the controls (χ2 = 15.48, df = 1, P < 0.001 OR = 2.73 95% CI: 1.64–4.56 by genotype; χ2 = 10.21, df = 1, P = 0.001 by allele). However in contrast, no association between genotype and relative allele frequencies was observed for the C [+3953] T polymorphism for Chinese women with PCOS when compared to that for a similar group of Chinese women without PCOS (P = 0.35).
Literatur
1.
Zurück zum Zitat P. Acién, F. Quereda, P. Matallín, E. Villarroya, J.A. López-Fernández, M. Acién, M. Mauri, R. Alfayate, Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil. Steril. 72, 32–40 (1999)CrossRefPubMed P. Acién, F. Quereda, P. Matallín, E. Villarroya, J.A. López-Fernández, M. Acién, M. Mauri, R. Alfayate, Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil. Steril. 72, 32–40 (1999)CrossRefPubMed
2.
Zurück zum Zitat E.-J. Lee, B. Oh, A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. Fertil. Steril. 89(5), 1213–1220 (2008)CrossRefPubMed E.-J. Lee, B. Oh, A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. Fertil. Steril. 89(5), 1213–1220 (2008)CrossRefPubMed
3.
Zurück zum Zitat P. Amato, J.L. Simpson, The genetics of polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 18, 707–718 (2004)CrossRefPubMed P. Amato, J.L. Simpson, The genetics of polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 18, 707–718 (2004)CrossRefPubMed
4.
Zurück zum Zitat E. Diamanti-Kandarakis, C. Piperi, Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum. Reprod. Update 11, 631–643 (2005)CrossRefPubMed E. Diamanti-Kandarakis, C. Piperi, Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum. Reprod. Update 11, 631–643 (2005)CrossRefPubMed
5.
Zurück zum Zitat M. Haap, F. Machicao, N. Stefan, C. Thamer, O. Tschritter, F. Schnuck, D. Wallwiener, M. Stumvoll, H.U. Häring, A. Fritsche, Genetic determinants of insulin action in polycystic ovary syndrome. Exp. Clin. Endocrinol. Diabetes 113, 275–281 (2005)CrossRefPubMed M. Haap, F. Machicao, N. Stefan, C. Thamer, O. Tschritter, F. Schnuck, D. Wallwiener, M. Stumvoll, H.U. Häring, A. Fritsche, Genetic determinants of insulin action in polycystic ovary syndrome. Exp. Clin. Endocrinol. Diabetes 113, 275–281 (2005)CrossRefPubMed
6.
Zurück zum Zitat P. Valdés, A. Cerda, C. Barrenechea, M. Kehr, C. Soto, L.A. Salazar, No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin. Chim. Acta 390(1–2), 63–69 (2008)CrossRefPubMed P. Valdés, A. Cerda, C. Barrenechea, M. Kehr, C. Soto, L.A. Salazar, No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin. Chim. Acta 390(1–2), 63–69 (2008)CrossRefPubMed
7.
Zurück zum Zitat E. Diamanti-Kandarakis, T. Paterakis, H.A. Kandarakis, Indices of low-grade inflammation in polycystic ovary syndrome. Ann. N.Y. Acad. Sci. 1092, 175–186 (2006)CrossRefPubMed E. Diamanti-Kandarakis, T. Paterakis, H.A. Kandarakis, Indices of low-grade inflammation in polycystic ovary syndrome. Ann. N.Y. Acad. Sci. 1092, 175–186 (2006)CrossRefPubMed
8.
Zurück zum Zitat J. Karasneh, A.H. Hajeer, J. Barrett, W.E. Ollier, M. Thornhill, A. Gul, Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet’s disease. Rheumatology 42, 860–864 (2003)CrossRefPubMed J. Karasneh, A.H. Hajeer, J. Barrett, W.E. Ollier, M. Thornhill, A. Gul, Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet’s disease. Rheumatology 42, 860–864 (2003)CrossRefPubMed
9.
Zurück zum Zitat X. He, L. Jiang, B. Fu, X. Zhang, Relationship between Interleukin-1B and Interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer. J. Jiangsu Univ. 16, 339–341 (2006) X. He, L. Jiang, B. Fu, X. Zhang, Relationship between Interleukin-1B and Interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer. J. Jiangsu Univ. 16, 339–341 (2006)
10.
Zurück zum Zitat D. Zhang, H. Zheng, Y. Zhou, X. Tang, B. Yu, J. Li, Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 7, 45 (2007) D. Zhang, H. Zheng, Y. Zhou, X. Tang, B. Yu, J. Li, Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 7, 45 (2007)
11.
Zurück zum Zitat A. Hurwitz, M. Dushnik, H. Solomon, A. Ben-Chetrit, Z. Finci-Yeheskel, A. Milwidsky, M. Mayer, E.Y. Adashi, S. Yagel, Cytokine-mediated regulation of rat ovarian function: interleukin-1 stimulates the accumulation of a 92-kilodalton gelatinase. Endocrinology 132(6), 2709–2714 (1993)CrossRefPubMed A. Hurwitz, M. Dushnik, H. Solomon, A. Ben-Chetrit, Z. Finci-Yeheskel, A. Milwidsky, M. Mayer, E.Y. Adashi, S. Yagel, Cytokine-mediated regulation of rat ovarian function: interleukin-1 stimulates the accumulation of a 92-kilodalton gelatinase. Endocrinology 132(6), 2709–2714 (1993)CrossRefPubMed
12.
Zurück zum Zitat E.E. Wallach, R. Bronson, Y. Hamada, K.H. Wright, V.C. Stevens, Effectiveness of prostaglandin F2 alpha in restoration of HMG-HCG induced ovulation in indomethacin-treated rhesus monkeys. Prostaglandins 10, 129–138 (1975)PubMed E.E. Wallach, R. Bronson, Y. Hamada, K.H. Wright, V.C. Stevens, Effectiveness of prostaglandin F2 alpha in restoration of HMG-HCG induced ovulation in indomethacin-treated rhesus monkeys. Prostaglandins 10, 129–138 (1975)PubMed
13.
Zurück zum Zitat L. Ainsworth, B.K. Tsang, B.R. Downey, R.D. Baker, G.J. Marcus, D.T. Armstrong, Effects of indomethacin on ovulation and luteal function in gilts. Biol. Reprod. 31, 115–121 (1979)CrossRef L. Ainsworth, B.K. Tsang, B.R. Downey, R.D. Baker, G.J. Marcus, D.T. Armstrong, Effects of indomethacin on ovulation and luteal function in gilts. Biol. Reprod. 31, 115–121 (1979)CrossRef
14.
Zurück zum Zitat E.D. Watson, P.L. Sertich, Concentrations of arachidonate metabolites, steroids and histamine in preovulatory horse follicles after administration of human chorionic gonadotrophin and the effect of intrafollicular injection of indomethacin. J. Endocrinol. 129, 131–139 (1991)CrossRefPubMed E.D. Watson, P.L. Sertich, Concentrations of arachidonate metabolites, steroids and histamine in preovulatory horse follicles after administration of human chorionic gonadotrophin and the effect of intrafollicular injection of indomethacin. J. Endocrinol. 129, 131–139 (1991)CrossRefPubMed
15.
Zurück zum Zitat M. Brännström, Inhibitory effect of mifepristone (RU 486) on ovulation in the isolated perfused rat ovary. Contraception 48, 393–402 (1993)CrossRefPubMed M. Brännström, Inhibitory effect of mifepristone (RU 486) on ovulation in the isolated perfused rat ovary. Contraception 48, 393–402 (1993)CrossRefPubMed
16.
Zurück zum Zitat B.J. Davis, D.E. Lennard, C.A. Lee, H.F. Tiano, S.G. Morham, W.C. Wetsel, R. Langenbach, Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1B. Endocrinology 140, 2685–2695 (1999)CrossRefPubMed B.J. Davis, D.E. Lennard, C.A. Lee, H.F. Tiano, S.G. Morham, W.C. Wetsel, R. Langenbach, Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1B. Endocrinology 140, 2685–2695 (1999)CrossRefPubMed
17.
Zurück zum Zitat M.J. De Los Santos, A. Mercader, A. Frances, E. Portolés, J. Remohí, A. Pellicer, C. Simón, Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol. Reprod. 54, 563–574 (1996)CrossRef M.J. De Los Santos, A. Mercader, A. Frances, E. Portolés, J. Remohí, A. Pellicer, C. Simón, Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol. Reprod. 54, 563–574 (1996)CrossRef
18.
Zurück zum Zitat A. Kolbus, K. Walch, F. Nagele, R. Wenzl, G. Unfried, J.C. Huber, Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome. J. Reprod. Immunol. 73, 188–193 (2007)CrossRefPubMed A. Kolbus, K. Walch, F. Nagele, R. Wenzl, G. Unfried, J.C. Huber, Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome. J. Reprod. Immunol. 73, 188–193 (2007)CrossRefPubMed
19.
Zurück zum Zitat H. Lee, B. Clark, H.C. Gooi, J. Stoves, C.G. Newstead, Influence of recipient and donor IL-1α, IL-4, and TNF-α genotypes on the incidence of acute renal allograft rejection. J. Clin. Pathol. 57(1), 101–103 (2004)CrossRefPubMed H. Lee, B. Clark, H.C. Gooi, J. Stoves, C.G. Newstead, Influence of recipient and donor IL-1α, IL-4, and TNF-α genotypes on the incidence of acute renal allograft rejection. J. Clin. Pathol. 57(1), 101–103 (2004)CrossRefPubMed
20.
Zurück zum Zitat Y. Yang, J. Qiao, M. Li, Study on the correlation between interleuKin 18, InteHeukin 1β and pathogenesis of polycystic ovary syndrome. Chin. J. Pract. Gynecol. Obstet. 24, 38–40 (2008) Y. Yang, J. Qiao, M. Li, Study on the correlation between interleuKin 18, InteHeukin 1β and pathogenesis of polycystic ovary syndrome. Chin. J. Pract. Gynecol. Obstet. 24, 38–40 (2008)
21.
Zurück zum Zitat F.S. Giovine, E. Takhsh, A.I. Blakemore, G.W. Duff, Single base polymorphism at −511 in the human interleukin-1 beta gene (IL-1 beta). Hum. Mol. Genet. 1, 450 (1992)CrossRefPubMed F.S. Giovine, E. Takhsh, A.I. Blakemore, G.W. Duff, Single base polymorphism at −511 in the human interleukin-1 beta gene (IL-1 beta). Hum. Mol. Genet. 1, 450 (1992)CrossRefPubMed
22.
Zurück zum Zitat Y. Wang, N. Kato, Y. Hoshida, H. Yoshida, H. Taniguchi, T. Goto, M. Moriyama, M. Otsuka, S. Shiina, Y. Shiratori, Y. Ito, M. Omata, Interleukin-1 beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37, 65–71 (2003)CrossRefPubMed Y. Wang, N. Kato, Y. Hoshida, H. Yoshida, H. Taniguchi, T. Goto, M. Moriyama, M. Otsuka, S. Shiina, Y. Shiratori, Y. Ito, M. Omata, Interleukin-1 beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37, 65–71 (2003)CrossRefPubMed
23.
Zurück zum Zitat E.M. El-Omar, M. Carrington, W.H. Chow, K.E. McColl, J.H. Bream, H.A. Young, J. Herrera, J. Lissowska, C.C. Yuan, N. Rothman, G. Lanyon, M. Martin, J.F. Fraumeni Jr., C.S. Rabkin, Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398–402 (2000)CrossRefPubMed E.M. El-Omar, M. Carrington, W.H. Chow, K.E. McColl, J.H. Bream, H.A. Young, J. Herrera, J. Lissowska, C.C. Yuan, N. Rothman, G. Lanyon, M. Martin, J.F. Fraumeni Jr., C.S. Rabkin, Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398–402 (2000)CrossRefPubMed
24.
Zurück zum Zitat H. Chen, L.M. Wilkins, N. Aziz, C. Cannings, D.H. Wyllie, C. Bingle, J. Rogus, J.D. Beck, S. Offenbacher, M.J. Cork, M. Rafie-Kolpin, C.M. Hsieh, K.S. Kornman, G.W. Duff, Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet. 15(4), 519–529 (2006)CrossRefPubMed H. Chen, L.M. Wilkins, N. Aziz, C. Cannings, D.H. Wyllie, C. Bingle, J. Rogus, J.D. Beck, S. Offenbacher, M.J. Cork, M. Rafie-Kolpin, C.M. Hsieh, K.S. Kornman, G.W. Duff, Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet. 15(4), 519–529 (2006)CrossRefPubMed
Metadaten
Titel
Interleukin 1 beta (IL-1β) promoter C [−511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome
verfasst von
Yuan Mu
Jingjing Liu
Binbin Wang
Qiaolian Wen
Jing Wang
Jinting Yan
Sirui Zhou
Xu Ma
Yunxia Cao
Publikationsdatum
01.02.2010
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2010
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9268-x

Weitere Artikel der Ausgabe 1/2010

Endocrine 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.